Tadao Akizawa

TL;DR: The results provide important information about mineral metabolism trends in hemodialysis patients in 12 countries during a decade and may be relevant to efforts at international harmonization of existing clinical guidelines for mineral metabolism.

TL;DR: Among patients with type 2 diabetes mellitus and stage 4 chronic kidney disease, bardoxolone methyl did not reduce the risk of end-stage renal disease (ESRD) or death from cardiovascular causes and was terminated on the recommendation of the independent data and safety monitoring committee.

TL;DR: This study expands the understanding of the relationship between altered mineral metabolism and outcomes and identifies several potential opportunities for improved practice in this area.

TL;DR: Patients consistently were less likely to use an AVF versus other VA types if female, of older age, having greater body mass index, diabetes, peripheral vascular disease or recurrent cellulitis/gangrene, and countries with a greater prevalence of diabetes in HD patients had a significantly lower percentage of patients using anAVF.

TL;DR: The results suggest that greater selectivity in prescribing several classes of psychoactive drugs and more efficient treatment of secondary hyperparathyroidism may help reduce the burden of fractures in HD patients.